Pharmacogenetic treatments for drug addiction: alcohol and opiates. (Q37201611)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18584566%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

review article

1 reference

title

Pharmacogenetic treatments for drug addiction: alcohol and opiates (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18584566%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18584566%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Therese A Kosten

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18584566%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

Thomas R Kosten

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18584566%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

publication date

1 January 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18584566%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Drug and Alcohol Abuse

9 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18584566%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18584566%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18584566%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

page(s)

355-381

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18584566%20AND%20SRC:MED&resulttype=core&format=json

Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine

9 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Association of an Asn40Asp (A118G) polymorphism in the mu-opioid receptor gene with substance dependence: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Types of alcoholics, I. Evidence for an empirically derived typology based on indicators of vulnerability and severity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Drug addiction: the neurobiology of disrupted self-control

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Association of a functional polymorphism in the mu-opioid receptor gene with alcohol response and consumption in male rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Increased attributable risk related to a functional mu-opioid receptor gene polymorphism in association with alcohol dependence in central Sweden

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Selective sensitization to the psychosis-inducing effects of cocaine: a possible marker for addiction relapse vulnerability?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Endophenotypes for psychiatric disorders: ready for primetime?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

A single nucleotide polymorphic mutation in the human mu-opioid receptor severely impairs receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

A medication screening trial evaluation of reserpine, gabapentin and lamotrigine pharmacotherapy of cocaine dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Effect of the A118G polymorphism on binding affinity, potency and agonist-mediated endocytosis, desensitization, and resensitization of the human mu-opioid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

21 January 2018

The many faces of CREB

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Limbic activation during cue-induced cocaine craving

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Human opioid receptor A118G polymorphism affects intravenous patient-controlled analgesia morphine consumption after total abdominal hysterectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

The dynamics of social learning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Abuse of prescription drugs and the risk of addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Clinical guidelines for psychiatrists for the use of pharmacogenetic testing for CYP450 2D6 and CYP450 2C19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Neurobiology of opiate abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Mu opioid receptor A118G polymorphism in association with striatal opioid neuropeptide gene expression in heroin abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Neural systems of reinforcement for drug addiction: from actions to habits to compulsion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

The A118G single nucleotide polymorphism of the mu-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Abstinence symptomatology and psychiatric diagnosis in cocaine abusers. Clinical observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Genetics of two mu opioid receptor gene (OPRM1) exon I polymorphisms: population studies, and allele frequencies in alcohol- and drug-dependent subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Lack of stimulant and anxiolytic-like effects of ethanol and accelerated development of ethanol dependence in mu-opioid receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

The pharmacogenetics research network: from SNP discovery to clinical drug response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Enhanced sensitivity of pituitary beta-endorphin to ethanol in subjects at high risk of alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

The genetics of addictions: uncovering the genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

The endophenotype concept in psychiatry: etymology and strategic intentions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Pharmacogenomics: a path to predictive medicine for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Genetics of dopamine and its contribution to cocaine addiction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Methamphetamine self-administration by humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Feeding increases dopamine metabolism in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Association between the cortisol response to opioid blockade and the Asn40Asp polymorphism at the mu-opioid receptor locus (OPRM1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Sequence variability and candidate gene analysis in complex disease: association of mu opioid receptor gene variation with substance dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Consumption of ethanol solution is potentiated by morphine and attenuated by naloxone persistently across repeated daily administrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Addiction: a disease of learning and memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Addiction and the brain: The neurobiology of compulsion and its persistence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Pharmacogenetics: potential for individualized drug therapy through genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Glutamate systems in cocaine addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Association of functional opioid receptor genotypes with alcohol dependence in Koreans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Effect of naltrexone on subjective alcohol response in subjects at high and low risk for future alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Drug addiction, dysregulation of reward, and allostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Plasticity of reward neurocircuitry and the 'dark side' of drug addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Buprenorphine for office-based practice: consensus conference overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Buprenorphine detoxification from opioid dependence: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Depressive symptoms during buprenorphine treatment of opioid abusers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Opioid receptors: some perspectives from early studies of their role in normal physiology, stress responsivity, and in specific addictive diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Genetic influences on impulsivity, risk taking, stress responsivity and vulnerability to drug abuse and addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

History and current status of opioid maintenance treatments: blending conference session

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Genetic markers of suicidal ideation emerging during citalopram treatment of major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Apomorphine in the evaluation of dopaminergic function in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

G-protein-coupled inwardly rectifying potassium channels are targets of alcohol action

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Evidence for genetic linkage to alcohol dependence on chromosomes 4 and 11 from an autosome-wide scan in an American Indian population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

The polymorphism A118G of the human mu-opioid receptor gene decreases the pupil constrictory effect of morphine-6-glucuronide but not that of morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Haplotypes at the OPRM1 locus are associated with susceptibility to substance dependence in European-Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Determinants of pressure pain threshold in adult twins: evidence that shared environmental influences predominate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Absence of opiate rewarding effects in mice lacking dopamine D2 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Pharmacogenetics of psychotropic drug response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Long-acting injectable naltrexone for the treatment of alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Clopidogrel resistance is associated with increased risk of recurrent atherothrombotic events in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Pharmacogenetics of opioid receptors and addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Naltrexone alters subjective and psychomotor responses to alcohol in heavy drinking subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Naltrexone dampens ethanol-induced cardiovascular and hypothalamic- pituitary-adrenal axis activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

In situ hybridization study of kappa-opioid receptor mRNA in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Melanocortin-1 receptor gene variants affect pain and mu-opioid analgesia in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Predicting treatment response to naltrexone: the influence of craving and family history

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Pharmacogenetics of antidepressant medication intolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Molecular neurobiology of addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Is there a common molecular pathway for addiction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Risperidone pre-treatment reduces the euphoric effects of experimentally administered cocaine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Anticraving medications for relapse prevention: a possible new class of psychoactive medications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Targeting treatments for alcohol dependence: the pharmacogenetics of naltrexone

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Association of CYP2D6 ultrarapid metabolizer genotype with deficient patient satisfaction regarding methadone maintenance treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Dopamine-dependent prediction errors underpin reward-seeking behaviour in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Investigation into the multidimensional genetic basis of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

A polymorphism of the mu-opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Effects of naltrexone on alcohol sensitivity and genetic moderators of medication response: a double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

The neural basis of drug craving: an incentive-sensitization theory of addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Pharmacogenetics of outcome in children with acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Pharmacogenetics affects dosing, efficacy, and toxicity of cytochrome P450-metabolized drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Attenuation of the euphoric effects of cocaine by the dopamine D1/D5 antagonist ecopipam (SCH 39166)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Pharmacogenetics and drug development: the path to safer and more effective drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Clinical response to morphine in cancer patients and genetic variation in candidate genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

A functional polymorphism within the mu-opioid receptor gene and risk for abuse of alcohol and other substances

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Plasma cortisol levels following ethanol in sons of alcoholics and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Cytochrome P450 polymorphisms and response to antipsychotic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Effects of intravenous cocaine are partially attenuated by haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Polymorphism screening in the cardiac K+ channel gene KCNA5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

The neurochemistry of morphine addiction in the neocortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

mu-opioid receptor variants and dopaminergic sensitivity in alcohol withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Pharmacogenetics of opioids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Mu opiate receptor gene dose effects on different morphine actions: evidence for differential in vivo mu receptor reserve.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Naltrexone for the treatment of alcoholism: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Genetics and variability in opioid response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Pharmacogenomics and anaesthesia: explaining the variability in response to opiates

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Naltrexone-induced alterations in human ethanol intoxication

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

TBX21: a functional variant predicts improvement in asthma with the use of inhaled corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Schizophrenia endophenotypes as treatment targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Morphine-6-glucuronide concentrations and opioid-related side effects: a survey in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Epigenetic regulation in psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

A functional polymorphism of the mu-opioid receptor gene (OPRM1) influences cue-induced craving for alcohol in male heavy drinkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Brain DA D2 receptors predict reinforcing effects of stimulants in humans: replication study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

How can drug addiction help us understand obesity?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Methamphetamine activates reward circuitry in drug naïve human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Naltrexone in the treatment of alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Naltrexone blocks the post-shock increase of ethanol consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Effect of naltrexone on alcohol "high" in alcoholics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

The mu-opioid receptor gene polymorphism (A118G) alters HPA axis activation induced by opioid receptor blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Gastric stimulation in obese subjects activates the hippocampus and other regions involved in brain reward circuitry

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Synaptic regulation of mesocorticolimbic dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Alcohol dependence, family history, and D2 dopamine receptor function as neuroendocrinologically assessed with apomorphine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Dopamine, learning and motivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Phosphodiesterase genes are associated with susceptibility to major depression and antidepressant treatment response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Subregions of the ventral striatum show preferential coding of reward magnitude and probability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

HLA-B*1502-bound peptides: implications for the pathogenesis of carbamazepine-induced Stevens-Johnson syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Deficit in beta-endorphin peptide and tendency to alcohol abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Effect of mu-opioid receptor gene polymorphisms on heroin-induced subjective responses in a Chinese population

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Association between two mu-opioid receptor gene (OPRM1) haplotype blocks and drug or alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

ABCB1 and cytochrome P450 genotypes and phenotypes: Influence on methadone plasma levels and response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00952990802122564

10.1080/00952990802122564

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18584566%20AND%20SRC:MED&resulttype=core&format=json

9 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18584566%20AND%20SRC:MED&resulttype=core&format=json